https://polypid.com/news/ 2026-05-30T08:12:40+00:00 https://polypid.com/news/techniques-in-coloproctology/ 2026-02-01T11:05:25+00:00 https://polypid.com/news/the-american-journal-of-surgery/ 2026-02-01T11:06:05+00:00 https://polypid.com/news/european-journal-of-pharmaceutical-sciences/ 2026-02-01T11:06:16+00:00 https://polypid.com/news/international-journal-of-toxicology/ 2026-02-01T11:06:27+00:00 https://polypid.com/news/international-journal-of-surgery/ 2026-02-01T11:06:48+00:00 https://polypid.com/news/asco-2022-annual-meeting/ 2026-02-04T12:24:06+00:00 https://polypid.com/news/quintessence-int/ 2026-02-04T12:29:24+00:00 https://polypid.com/news/toxicologic-pathology-2/ 2026-02-04T12:30:29+00:00 https://polypid.com/news/advanced-functional-materials/ 2026-02-04T12:31:16+00:00 https://polypid.com/news/journal-of-controlled-release/ 2026-02-04T12:33:05+00:00 https://polypid.com/news/journal-of-controlled-release-2/ 2026-02-04T12:33:52+00:00 https://polypid.com/news/journal-of-controlled-release-3/ 2026-02-04T12:35:32+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-2025-financial-results-and-operational-highlights-on-february-11-2026/ 2026-02-05T07:29:11+00:00 https://polypid.com/news/polypid-to-participate-in-roth-capital-partners-virtual-kol-event-on-december-10-2025/ 2026-02-05T08:36:38+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2025-financial-results-and-operational-highlights-on-november-12-2025/ 2026-02-05T08:40:17+00:00 https://polypid.com/news/polypid-to-present-its-positive-phase-3-shield-ii-topline-results-at-the-2025-american-college-of-surgeons-clinical-congress/ 2026-02-05T08:41:13+00:00 https://polypid.com/news/polypid-to-present-at-lytham-partners-fall-2025-investor-conference-and-participate-in-4th-annual-roth-healthcare-opportunities-conference/ 2026-02-05T10:00:03+00:00 https://polypid.com/news/polypid-to-present-at-the-14th-meeting-of-the-israel-controlled-release-society-conference/ 2026-02-05T10:00:38+00:00 https://polypid.com/news/polypid-to-host-conference-call-and-webcast-to-discuss-d-plex%e2%82%81%e2%82%80%e2%82%80-shield-ii-phase-3-trial-topline-results-on-monday-june-9-2025/ 2026-02-05T10:02:50+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2025-financial-results-and-operational-highlights-on-august-13-2025/ 2026-02-05T10:03:41+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2025-financial-results-and-operational-highlights-on-may-14-2025/ 2026-02-05T10:04:55+00:00 https://polypid.com/news/polypid-to-participate-in-the-citizens-life-sciences-conference/ 2026-02-05T10:06:14+00:00 https://polypid.com/news/polypid-to-participate-in-the-37th-annual-roth-conference/ 2026-02-05T10:44:53+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-12-2025/ 2026-02-05T10:45:44+00:00 https://polypid.com/news/polypid-to-participate-in-the-oppenheimer-35th-annual-healthcare-life-sciences-conference/ 2026-02-05T10:46:30+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-2025-financial-results-and-operational-highlights-on-february-11-2026-2/ 2026-02-05T12:05:40+00:00 https://polypid.com/news/polypid-appoints-veteran-medtech-leader-brooke-story-as-chairman-of-the-board-of-directors/ 2026-02-05T12:06:37+00:00 https://polypid.com/news/polypid-announces-positive-fda-pre-nda-meeting-minutes-for-d-plex%e2%82%81%e2%82%80%e2%82%80-supporting-nda-submission/ 2026-02-05T12:07:34+00:00 https://polypid.com/news/polypid-to-participate-in-roth-capital-partners-virtual-kol-event-on-december-10-2025-2/ 2026-02-05T12:08:21+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-third-quarter-2025-financial-results/ 2026-02-05T12:09:08+00:00 https://polypid.com/news/polypids-d-plex%e2%82%81%e2%82%80%e2%82%80-wins-biotech-breakthrough-award-for-therapeutics-solution-of-the-year/ 2026-02-05T12:10:01+00:00 https://polypid.com/news/polypid-to-present-at-lytham-partners-fall-2025-investor-conference-and-participate-in-4th-annual-roth-healthcare-opportunities-conference-2/ 2026-02-05T12:12:27+00:00 https://polypid.com/news/polypid-successfully-completes-israeli-ministry-of-health-gmp-inspection-advancing-towards-commercial-manufacturing-readiness-for-d-plex%e2%82%81%e2%82%80%e2%82%80/ 2026-02-05T12:13:11+00:00 https://polypid.com/news/polypid-to-participate-in-the-upcoming-27th-annual-h-c-wainwright-global-investment-conference/ 2026-02-05T12:13:57+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2025-financial-results-and-operational-highlights-on-november-12-2025-2/ 2026-02-05T16:08:27+00:00 https://polypid.com/news/polypid-to-present-its-positive-phase-3-shield-ii-topline-results-at-the-2025-american-college-of-surgeons-clinical-congress-2/ 2026-02-05T16:08:35+00:00 https://polypid.com/news/polypid-to-present-at-the-14th-meeting-of-the-israel-controlled-release-society-conference-2/ 2026-02-08T08:30:56+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-second-quarter-2025-financial-results/ 2026-02-08T08:31:43+00:00 https://polypid.com/news/polypid-appoints-dr-nurit-tweezer-zaks-as-chief-medical-officer/ 2026-02-08T08:32:34+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2025-financial-results-and-operational-highlights-on-august-13-2025-2/ 2026-02-08T08:33:42+00:00 https://polypid.com/news/polypid-unveils-a-long-acting-glp-1-receptor-agonists-delivery-platform-targeting-the-diabetes-and-weight-loss-market/ 2026-02-08T08:34:31+00:00 https://polypid.com/news/polypid-secures-26-7-million-through-warrant-exercise-following-successful-shield-ii-phase-3-trial-results/ 2026-02-08T08:35:16+00:00 https://polypid.com/news/polypid-announces-positive-topline-results-from-phase-3-shield-ii-trial-d-plex%e2%82%81%e2%82%80%e2%82%80-demonstrated-significant-reduction-in-surgical-site-infections-and-successfully-met-primary-a/ 2026-02-08T08:36:11+00:00 https://polypid.com/news/polypid-to-host-conference-call-and-webcast-to-discuss-d-plex%e2%82%81%e2%82%80%e2%82%80-shield-ii-phase-3-trial-topline-results-on-monday-june-9-2025-2/ 2026-02-08T08:36:53+00:00 https://polypid.com/news/polypid-to-participate-in-the-lytham-partners-spring-2025-investor-conference-on-may-29-2025/ 2026-02-08T08:37:32+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-first-quarter-2025-financial-results/ 2026-02-08T08:38:31+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2025-financial-results-and-operational-highlights-on-may-14-2025-2/ 2026-02-08T08:41:09+00:00 https://polypid.com/news/polypid-to-participate-in-the-citizens-life-sciences-conference-2/ 2026-02-08T08:41:59+00:00 https://polypid.com/news/polypid-announces-successful-completion-of-enrollment-in-phase-3-shield-ii-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-abdominal-colorectal-surgical-site-infections/ 2026-02-08T08:42:48+00:00 https://polypid.com/news/polypid-to-participate-in-the-37th-annual-roth-conference-2/ 2026-02-08T08:43:47+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2024-financial-results/ 2026-02-08T08:44:32+00:00 https://polypid.com/news/polypid-to-participate-in-the-oppenheimer-35th-annual-healthcare-life-sciences-conference-2/ 2026-02-08T08:45:53+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-12-2025-2/ 2026-02-08T08:46:46+00:00 https://polypid.com/news/polypid-announces-positive-recommendation-by-dsmb-to-continue-enrollment-of-phase-3-shield-ii-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-to-800-patients-with-a-concurrent-private-placement-of-up-to-4/ 2026-02-08T09:04:38+00:00 https://polypid.com/news/polypid-announces-research-and-development-collaboration-with-immunogenesis-leveraging-plex-technology-to-enhance-cancer-immunotherapy/ 2026-02-08T09:05:45+00:00 https://polypid.com/news/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance/ 2026-02-08T09:06:38+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-third-quarter-2024-financial-results/ 2026-02-08T09:07:25+00:00 https://polypid.com/news/polypid-to-participate-in-the-craig-hallum-15th-annual-alpha-select-conference/ 2026-02-08T09:08:03+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2024-financial-results-and-operational-highlights-on-november-13-2024/ 2026-02-08T09:09:00+00:00 https://polypid.com/news/polypid-announces-publication-in-international-journal-of-surgery-highlighting-results-of-phase-3-shield-i-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-in-prevention-of-surgical-site-infections-in-abdom/ 2026-02-08T09:09:43+00:00 https://polypid.com/news/polypid-announces-last-patient-in-for-planned-unblinded-interim-analysis-in-the-ongoing-shield-ii-phase-3-trial-evaluating-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-abdominal-colorectal/ 2026-02-08T09:10:24+00:00 https://polypid.com/news/polypid-to-participate-in-three-upcoming-fall-investor-conference/ 2026-02-08T09:11:11+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-second-quarter-2024-financial-results/ 2026-02-08T09:11:50+00:00 https://polypid.com/news/polypid-announces-private-placement-for-up-to-14-million-in-gross-proceeds/ 2026-02-08T09:13:02+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2024-financial-results-and-operational-highlights-on-august-14-2024/ 2026-02-08T09:13:46+00:00 https://polypid.com/news/polypid-hosts-kol-call-to-discuss-significant-unmet-medical-need-in-surgical-site-infections-prevention-and-provides-update-on-its-ongoing-shield-ii-phase-3-trial/ 2026-02-08T09:14:25+00:00 https://polypid.com/news/polypid-to-host-virtual-kol-event-on-june-17-2024-and-provide-an-update-on-the-companys-ongoing-d-plex%e2%82%81%e2%82%80%e2%82%80-phase-3-trial/ 2026-02-08T09:15:22+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-first-quarter-2024-financial-results/ 2026-02-08T09:16:02+00:00 https://polypid.com/news/polypid-to-participate-in-citizens-jmp-life-sciences-conference/ 2026-02-08T09:16:46+00:00 https://polypid.com/news/polypid-announces-enrollment-of-200th-patient-in-ongoing-shield-ii-phase-3-trial-evaluating-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-abdominal-colorectal-surgical-site-infections/ 2026-02-08T09:17:30+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2024-financial-results-and-operational-highlights-on-may-8-2024/ 2026-02-08T09:18:18+00:00 https://polypid.com/news/polypid-to-participate-in-barclays-26th-annual-global-healthcare-conference/ 2026-02-08T09:19:00+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2023-financial-results/ 2026-02-08T09:19:35+00:00 https://polypid.com/news/polypid-announces-enrollment-of-the-100th-patient-in-the-ongoing-shield-ii-phase-3-trial/ 2026-02-08T09:20:50+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2023-financial-results-and-operational-highlights-on-february-14-2024/ 2026-02-08T09:21:29+00:00 https://polypid.com/news/polypid-announces-private-placement-for-16-million-in-gross-proceeds/ 2026-02-08T09:22:05+00:00 https://polypid.com/news/polypid-announces-the-addition-of-dr-nurit-tweezer-zaks-to-its-board-of-directors/ 2026-02-08T09:24:55+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-third-quarter-2023-financial-results/ 2026-02-08T09:25:23+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2023-financial-results-and-operational-highlights-on-november-8-2023/ 2026-02-08T09:26:06+00:00 https://polypid.com/news/polypid-regains-compliance-with-nasdaq-minimum-closing-bid-price-rule/ 2026-02-08T09:26:45+00:00 https://polypid.com/news/polypid-announces-presentation-at-the-american-college-of-surgeons-clinical-congress-2023/ 2026-02-08T09:27:23+00:00 https://polypid.com/news/polypid-announces-publication-of-preclinical-data-further-supporting-the-good-safety-profile-of-d-plex%e2%82%81%e2%82%80%e2%82%80-and-plex-technology-platform/ 2026-02-08T09:28:06+00:00 https://polypid.com/news/polypid-to-present-at-the-2023-cantor-fitzgerald-global-healthcare-conference/ 2026-02-08T09:28:53+00:00 https://polypid.com/news/polypid-announces-successful-commercial-good-manufacturing-practice-gmp-audit-by-israeli-ministry-of-health/ 2026-02-08T09:29:30+00:00 https://polypid.com/news/polypid-announces-reverse-share-split/ 2026-02-08T09:30:32+00:00 https://polypid.com/news/polypid-announces-successful-completion-of-manufacturing-process-validation-for-d-plex%e2%82%81%e2%82%80%e2%82%80/ 2026-02-08T09:31:10+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-second-quarter-2023-financial-results/ 2026-02-08T09:58:06+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2023-financial-results-and-operational-highlights-on-august-9-2023/ 2026-02-08T09:58:52+00:00 https://polypid.com/news/polypid-announces-new-publication-highlighting-potent-antibacterial-activity-of-d-plex%e2%82%81%e2%82%80%e2%82%80-against-susceptible-and-resistant-bacteria-for-the-prevention-of-surgical-site-infecti/ 2026-02-08T09:59:41+00:00 https://polypid.com/news/polypid-announces-recruitment-of-first-patient-in-revised-shield-ii-phase-3-trial-evaluating-d-plex%e2%82%81%e2%82%80%e2%82%80-for-prevention-of-abdominal-colorectal-surgical-site-infections/ 2026-02-08T10:00:20+00:00 https://polypid.com/news/polypid-announces-180-day-extension-to-regain-compliance-with-nasdaq-minimum-bid-requirement-and-transfer-of-its-listing-to-the-nasdaq-capital-market/ 2026-02-08T10:01:03+00:00 https://polypid.com/news/polypid-announces-fda-agreement-on-the-design-of-shield-ii-phase-3-trial-evaluating-d-plex%e2%82%81%e2%82%80%e2%82%80-for-prevention-of-abdominal-colorectal-surgical-site-infections/ 2026-02-08T10:01:39+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-first-quarter-2023-financial-results/ 2026-02-08T10:02:20+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2023-financial-results-and-operational-highlights-on-may-10-2023/ 2026-02-08T10:02:57+00:00 https://polypid.com/news/polypid-to-participate-in-upcoming-investor-conferences/ 2026-02-08T10:03:33+00:00 https://polypid.com/news/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2/ 2026-02-08T10:04:09+00:00 https://polypid.com/news/polypid-announces-closing-of-underwritten-public-offering-including-full-exercise-of-overallotment-option-and-concurrent-private-placement-with-11-4-million-in-aggregate-gross-proceeds/ 2026-02-08T10:06:32+00:00 https://polypid.com/news/polypid-announces-pricing-of-6-2-million-underwritten-public-offering-of-ordinary-shares-and-concurrent-4-4-million-private-placement-of-pre-funded-warrants/ 2026-02-08T10:07:26+00:00 https://polypid.com/news/polypid-announces-proposed-underwritten-public-offering-of-ordinary-shares/ 2026-02-08T10:08:11+00:00 https://polypid.com/news/polypid-to-present-at-the-barclays-global-healthcare-conference/ 2026-02-08T10:08:55+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2022-financial-results/ 2026-02-08T10:09:31+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2022-financial-results-and-operational-highlights-on-february-8-2023/ 2026-02-08T10:10:07+00:00 https://polypid.com/news/polypid-provides-positive-regulatory-update-for-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infections-in-abdominal-colorectal-surgery/ 2026-02-08T10:10:40+00:00 https://polypid.com/news/polypid-announces-publication-in-the-american-journal-of-surgery-of-phase-2-clinical-trial-post-hoc-analysis-for-d-plex%e2%82%81%e2%82%80%e2%82%80-in-the-prevention-of-surgical-site-infections-in-abdo/ 2026-02-08T10:11:15+00:00 https://polypid.com/news/polypid-announces-scheduling-of-type-d-meeting-with-u-s-fda-to-discuss-shield-i-phase-3-results-and-regulatory-pathway-for-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infect/ 2026-02-08T10:31:10+00:00 https://polypid.com/news/polypid-announces-receipt-of-nasdaq-minimum-bid-price-notification/ 2026-02-08T10:32:07+00:00 https://polypid.com/news/polypid-announces-presentation-of-phase-2-d-plex%e2%82%81%e2%82%80%e2%82%80-clinical-data-at-the-first-triennial-meeting-of-the-international-orthopaedic-trauma-association/ 2026-02-08T10:33:03+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-third-quarter-2022-financial-results/ 2026-02-08T10:33:54+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2022-financial-results-and-operational-highlights-on-november-9-2022/ 2026-02-08T10:34:34+00:00 https://polypid.com/news/polypid-announces-cost-reduction-plan/ 2026-02-08T10:35:13+00:00 https://polypid.com/news/polypid-announces-eligibility-for-european-medicines-agency-centralized-procedure-for-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T10:35:55+00:00 https://polypid.com/news/polypid-announces-peer-reviewed-publication-of-phase-2-clinical-trial-results-for-d-plex%e2%82%81%e2%82%80%e2%82%80-in-the-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T10:36:31+00:00 https://polypid.com/news/polypid-announces-presentation-of-phase-2-d-plex%e2%82%81%e2%82%80%e2%82%80-clinical-data-at-the-european-society-for-coloproctology-scientific-conference/ 2026-02-08T10:37:11+00:00 https://polypid.com/news/polypid-announces-top-line-results-of-phase-3-shield-i-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T10:37:48+00:00 https://polypid.com/news/polypid-announces-presentation-at-the-2022-military-health-system-research-symposium/ 2026-02-08T10:39:36+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-second-quarter-2022-financial-results/ 2026-02-08T10:40:39+00:00 https://polypid.com/news/polypid-announces-exclusive-licensing-agreement-with-advanz-pharma-for-the-commercialization-of-d-plex%e2%82%81%e2%82%80%e2%82%80-in-europe/ 2026-02-08T10:41:32+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2022-financial-results-and-operational-highlights-on-august-10-2022/ 2026-02-08T10:42:08+00:00 https://polypid.com/news/polypid-announces-presentation-of-phase-2-d-plex%e2%82%81%e2%82%80%e2%82%80-clinical-data-at-the-midwest-surgical-association-2022-annual-meeting/ 2026-02-08T10:42:51+00:00 https://polypid.com/news/polypid-announces-dikla-czaczkes-akselbrad-assumes-role-of-ceo/ 2026-02-08T10:43:35+00:00 https://polypid.com/news/polypid-hosting-key-opinion-leader-webinar-on-managing-the-cost-of-surgical-site-infections/ 2026-02-08T10:44:21+00:00 https://polypid.com/news/polypid-announces-presentation-of-d-plex%e2%82%81%e2%82%80%e2%82%80-phase-2-clinical-data-at-asm-microbe-2022/ 2026-02-08T10:45:33+00:00 https://polypid.com/news/polypid-to-present-at-the-jmp-securities-2022-life-sciences-conference/ 2026-02-08T10:46:11+00:00 https://polypid.com/news/polypid-announces-publication-of-animal-model-studies-in-2022-asco-annual-meeting-abstract-demonstrating-that-locally-administered-oncoplex-potentially-decreases-the-likelihood-of-tumor-recurrence-wit/ 2026-02-08T10:46:47+00:00 https://polypid.com/news/polypid-announces-completion-of-enrollment-in-phase-3-shield-i-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T11:17:40+00:00 https://polypid.com/news/polypid-announces-recommendation-by-data-safety-monitoring-board-to-conclude-enrollment-of-phase-3-shield-i-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-at-the-minimum-number-of-patients-targeted-follow/ 2026-02-08T11:18:25+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-first-quarter-2022-financial-results/ 2026-02-08T11:19:23+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2022-financial-results-and-operational-highlights-on-may-11-2022/ 2026-02-08T11:19:55+00:00 https://polypid.com/news/polypid-announces-presentation-at-the-13th-european-and-global-clinam-summit-for-nanomedicine/ 2026-02-08T11:20:35+00:00 https://polypid.com/news/polypid-announces-presentation-of-clinical-data-at-surgical-infection-society-2022-annual-meeting/ 2026-02-08T11:21:25+00:00 https://polypid.com/news/polypid-secures-15-million-non-dilutive-secured-term-loan-facility/ 2026-02-08T11:22:00+00:00 https://polypid.com/news/polypid-to-deliver-poster-presentation-at-sages-2022/ 2026-02-08T11:22:37+00:00 https://polypid.com/news/polypid-announces-750th-patient-enrolled-in-shield-i-phase-3-clinical-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-in-abdominal-surgery/ 2026-02-08T11:23:16+00:00 https://polypid.com/news/polypid-to-present-at-the-barclays-global-healthcare-conference-2/ 2026-02-08T11:23:47+00:00 https://polypid.com/news/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2021-financial-results/ 2026-02-08T11:24:35+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2021-financial-results-and-operational-highlights-on-february-9-2022/ 2026-02-08T11:25:12+00:00 https://polypid.com/news/polypid-appoints-ucsf-brain-tumor-center-director-mitchel-s-berger-m-d-to-oncology-advisory-board/ 2026-02-08T11:25:44+00:00 https://polypid.com/news/polypid-announces-planned-ceo-transition/ 2026-02-08T11:26:17+00:00 https://polypid.com/news/polypid-announces-500th-patient-enrolled-in-shield-i-phase-3-clinical-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-in-abdominal-surgery/ 2026-02-08T11:29:09+00:00 https://polypid.com/news/polypid-appoints-new-oncology-advisory-board-member/ 2026-02-08T11:29:43+00:00 https://polypid.com/news/polypid-ltd-reports-third-quarter-2021-financial-results-and-provides-corporate-update/ 2026-02-08T11:30:26+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2021-financial-results-and-operational-highlights-on-november-10-2021/ 2026-02-08T11:31:01+00:00 https://polypid.com/news/polypid-to-present-at-upcoming-cantor-fitzgerald-global-healthcare-conference/ 2026-02-08T11:31:36+00:00 https://polypid.com/news/polypid-announces-positive-preclinical-data-of-its-intra-tumoral-oncoplex-in-brain-cancer/ 2026-02-08T11:32:06+00:00 https://polypid.com/news/polypid-to-present-at-first-world-association-against-infection-in-orthopaedics-and-trauma-congress/ 2026-02-08T11:33:03+00:00 https://polypid.com/news/polypid-ltd-reports-second-quarter-2021-financial-results-and-provides-corporate-update/ 2026-02-08T11:33:48+00:00 https://polypid.com/news/polypid-to-present-at-the-investor-summit-virtual-conference-on-august-18-2021/ 2026-02-08T11:34:23+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2021-financial-results-and-operational-highlights-on-august-11-2021/ 2026-02-08T11:34:56+00:00 https://polypid.com/news/polypid-strengthens-executive-team-appointing-dr-anthony-senagore-as-senior-medical-director/ 2026-02-08T11:35:41+00:00 https://polypid.com/news/polypid-presents-today-at-the-raymond-james-human-health-innovation-conference/ 2026-02-08T11:36:34+00:00 https://polypid.com/news/polypid-to-present-at-upcoming-healthcare-investor-conferences/ 2026-02-08T11:37:13+00:00 https://polypid.com/news/polypid-announces-positive-fda-type-b-meeting-feedback-for-d-plex%e2%82%81%e2%82%80%e2%82%80-development-program/ 2026-02-08T11:37:49+00:00 https://polypid.com/news/polypid-ltd-reports-first-quarter-2021-financial-results-and-provides-corporate-update/ 2026-02-08T11:38:33+00:00 https://polypid.com/news/polypid-to-report-first-quarter-2021-financial-results-and-operational-highlights-on-may-12-2021/ 2026-02-08T11:39:07+00:00 https://polypid.com/news/polypid-to-participate-in-upcoming-investor-conferences-2/ 2026-02-08T11:39:56+00:00 https://polypid.com/news/polypid-announces-100th-patient-enrolled-in-shield-i-phase-3-clinical-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-post-abdominal-surgery-incisional-infections/ 2026-02-08T11:40:31+00:00 https://polypid.com/news/polypid-ltd-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2020-financial-results/ 2026-02-08T11:41:11+00:00 https://polypid.com/news/polypid-to-report-fourth-quarter-and-full-year-2020-financial-results-and-operational-highlights-on-february-10-2021/ 2026-02-08T11:41:43+00:00 https://polypid.com/news/polypid-announces-positive-preclinical-data-from-oncoplex-intra-tumoral-cancer-therapy-program/ 2026-02-08T11:51:47+00:00 https://polypid.com/news/polypid-initiates-shield-ii-second-phase-3-clinical-trial-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-post-abdominal-surgery-incisional-infections/ 2026-02-08T11:52:31+00:00 https://polypid.com/news/polypid-to-host-key-opinion-leader-call-discussing-d-plex%e2%82%81%e2%82%80%e2%82%80-and-the-prevention-of-surgical-site-infections/ 2026-02-08T11:53:08+00:00 https://polypid.com/news/polypid-granted-breakthrough-therapy-designation-from-fda-for-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infections-in-colorectal-surgery/ 2026-02-08T11:53:40+00:00 https://polypid.com/news/polypid-ltd-provides-corporate-update-and-reports-third-quarter-2020-financial-results/ 2026-02-08T11:54:37+00:00 https://polypid.com/news/polypid-to-participate-in-three-upcoming-investor-conferences/ 2026-02-08T11:55:15+00:00 https://polypid.com/news/polypid-to-report-third-quarter-2020-financial-results-and-operational-highlights-on-november-11-2020/ 2026-02-08T11:55:48+00:00 https://polypid.com/news/polypid-ltd-provides-corporate-update-and-reports-second-quarter-2020-financial-results/ 2026-02-08T11:56:21+00:00 https://polypid.com/news/polypid-to-report-second-quarter-2020-financial-results-and-operational-highlights-on-august-19-2020/ 2026-02-08T11:56:57+00:00 https://polypid.com/news/polypid-granted-fast-track-designation-from-fda-for-d-plex%e2%82%81%e2%82%80%e2%82%80-for-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T11:57:50+00:00 https://polypid.com/news/polypid-to-present-phase-2-results-of-d-plex%e2%82%81%e2%82%80%e2%82%80-for-the-prevention-of-surgical-site-infections-in-abdominal-surgery-at-the-american-society-of-colon-and-rectal-surgeons-2020-an/ 2026-02-08T11:58:48+00:00 https://polypid.com/news/polypid-ltd-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2026-02-08T12:00:13+00:00 https://polypid.com/news/polypid-announces-the-initiation-of-a-phase-3-clinical-trial-of-d-plex100-for-the-prevention-of-sternal-wound-infection-post-cardiac-surgery/ 2026-02-08T12:01:33+00:00 https://polypid.com/news/polypid-ltd-announces-pricing-of-initial-public-offering/ 2026-02-08T12:01:52+00:00 https://polypid.com/news/polypid-initiates-first-phase-3-clinical-trial-of-d-plex100-for-the-prevention-of-post-abdominal-surgery-incisional-infections/ 2026-02-08T12:07:24+00:00 https://polypid.com/news/polypid-announces-positive-top-line-results-from-phase-2-clinical-trial-of-d-plex100-for-the-prevention-of-surgical-site-infections-in-abdominal-surgery/ 2026-02-08T12:08:19+00:00 https://polypid.com/news/polypid-announces-completion-of-50-million-series-e-1-financing/ 2026-02-08T12:08:56+00:00 https://polypid.com/news/polypid-receives-a-second-qidp-designation-for-d-plex100-in-abdominal-surgery/ 2026-02-08T12:09:39+00:00 https://polypid.com/news/polypid-begins-phase-2-study-to-assess-safety-and-efficacy-of-d-plex100-in-prevention-of-abdominal-surgical-site-infections/ 2026-02-08T12:11:20+00:00 https://polypid.com/news/polypid-has-received-certificate-of-gmp-compliance-of-a-manufacturer/ 2026-02-08T12:11:55+00:00 https://polypid.com/news/the-european-society-of-coloproctology-escp-2022-annual-meeting/ 2026-02-11T20:05:05+00:00 https://polypid.com/news/european-cells-and-materials-2/ 2026-02-12T06:15:12+00:00 https://polypid.com/news/european-cells-and-materials/ 2026-02-12T06:34:45+00:00 https://polypid.com/news/2025-american-college-of-surgeons-acs-clinical-congress/ 2026-02-12T06:40:42+00:00 https://polypid.com/news/13th-european-and-global-clinam-summit/ 2026-02-12T06:41:48+00:00 https://polypid.com/news/american-college-of-surgeons-clinical-conference-2023/ 2026-02-12T06:42:35+00:00 https://polypid.com/news/european-cells-and-materials-3/ 2026-02-12T06:46:48+00:00 https://polypid.com/news/asm-american-society-for-microbiology-microbe-annual-meeting-2022/ 2026-02-12T17:07:40+00:00 https://polypid.com/news/surgical-infection-society-sis-41st-annual-meeting/ 2026-02-12T17:08:25+00:00 https://polypid.com/news/the-2022-military-health-system-research-symposium-mhsrs/ 2026-02-25T09:14:53+00:00 https://polypid.com/news/msa-2022-annual-meeting/ 2026-02-25T09:16:38+00:00 https://polypid.com/news/sages-2022-annual-meeting-the-next-big-thing/ 2026-02-25T09:19:14+00:00 https://polypid.com/news/journal-of-cardiac-surgery/ 2026-02-25T09:20:50+00:00 https://polypid.com/news/toxicologic-pathology/ 2026-02-25T09:22:21+00:00 https://polypid.com/news/2026-congress-of-the-european-society-of-clinical-microbiology-and-infectious-diseases-escmid-global/ 2026-04-25T11:17:15+00:00 https://polypid.com/news/surgical-infection-society-45th-annual-meeting/ 2026-05-07T05:19:55+00:00 https://polypid.com/news/american-society-of-clinical-oncology-asco/ 2026-05-30T08:12:40+00:00